{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:04:18Z","timestamp":1777053858756,"version":"3.51.4"},"reference-count":87,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Centre in Poland","award":["2020\/39\/B\/NZ2\/00584"],"award-info":[{"award-number":["2020\/39\/B\/NZ2\/00584"]}]},{"name":"University of Warsaw","award":["2020\/39\/B\/NZ2\/00584"],"award-info":[{"award-number":["2020\/39\/B\/NZ2\/00584"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Chemokines modulate the immune response by regulating the migration of immune cells. They are also known to participate in such processes as cell\u2013cell adhesion, allograft rejection, and angiogenesis. Chemokines interact with two different subfamilies of G protein-coupled receptors: conventional chemokine receptors and atypical chemokine receptors. Here, we focused on the former one which has been linked to many inflammatory diseases, including: multiple sclerosis, asthma, nephritis, and rheumatoid arthritis. Available crystal and cryo-EM structures and homology models of six chemokine receptors (CCR1 to CCR6) were described and tested in terms of their usefulness in structure-based drug design. As a result of structure-based virtual screening for CCR2 and CCR3, several new active compounds were proposed. Known inhibitors of CCR1 to CCR6, acquired from ChEMBL, were used as training sets for two machine learning algorithms in ligand-based drug design. Performance of LightGBM was compared with a sequential Keras\/TensorFlow model of neural network for these diverse datasets. A combination of structure-based virtual screening with machine learning allowed to propose several active ligands for CCR2 and CCR3 with two distinct compounds predicted as CCR3 actives by all three tested methods: Glide, Keras\/TensorFlow NN, and LightGBM. In addition, the performance of these three methods in the prediction of the CCR2\/CCR3 receptor subtype selectivity was assessed.<\/jats:p>","DOI":"10.3390\/pharmaceutics15020516","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T04:25:28Z","timestamp":1675657528000},"page":"516","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Chemokine Receptors\u2014Structure-Based Virtual Screening Assisted by Machine Learning"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-5322","authenticated-orcid":false,"given":"Paulina","family":"Dragan","sequence":"first","affiliation":[{"name":"Faculty of Chemistry, University of Warsaw, 02-093 Warsaw, Poland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1844-6997","authenticated-orcid":false,"given":"Matthew","family":"Merski","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry, University of Warsaw, 02-093 Warsaw, Poland"}]},{"given":"Szymon","family":"Wi\u015bniewski","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry, University of Warsaw, 02-093 Warsaw, Poland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6827-7960","authenticated-orcid":false,"given":"Swapnil Ganesh","family":"Sanmukh","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry, University of Warsaw, 02-093 Warsaw, Poland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0429-0637","authenticated-orcid":false,"given":"Dorota","family":"Latek","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry, University of Warsaw, 02-093 Warsaw, Poland"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev.pharmtox.42.091901.115838","article-title":"Structure, Function, and Inhibition of Chemokines","volume":"42","author":"Fernandez","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.113.007724","article-title":"International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors","volume":"66","author":"Bachelerie","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1038\/onc.2013.272","article-title":"Inflammatory Chemokines and Metastasis\u2014Tracing the Accessory","volume":"33","author":"Borsig","year":"2014","journal-title":"Oncogene"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"107799","DOI":"10.1016\/j.pharmthera.2020.107799","article-title":"Role of Inflammatory Chemokines in Hypertension","volume":"223","author":"Mikolajczyk","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A Guide to Chemokines and Their Receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/84209","article-title":"Chemokines and Disease","volume":"2","author":"Gerard","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2741\/3261","article-title":"Chemokines and Chemokine Receptors: An Overview","volume":"14","author":"Bonecchi","year":"2009","journal-title":"Front. Biosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcp.2016.04.007","article-title":"New Paradigms in Chemokine Receptor Signal Transduction: Moving beyond the Two-Site Model","volume":"114","author":"Kleist","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"D680","DOI":"10.1093\/nar\/gkn728","article-title":"IUPHAR-DB: The IUPHAR Database of G Protein-Coupled Receptors and Ion Channels","volume":"37","author":"Harmar","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Stone, M.J., Hayward, J.A., Huang, C., Huma, Z.E., and Sanchez, J. (2017). Mechanisms of Regulation of the Chemokine-Receptor Network. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020342"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nri722","article-title":"Chemokine Receptors: Multifaceted Therapeutic Targets","volume":"2","author":"Proudfoot","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/1568010023344715","article-title":"Eotaxin Receptor (CCR3) Antagonism in Asthma and Allergic Disease","volume":"1","author":"Erin","year":"2002","journal-title":"Curr. Drug Targets-Inflamm. Allergy"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"15038","DOI":"10.1038\/s41598-017-11868-9","article-title":"A New Antagonist for CCR4 Attenuates Allergic Lung Inflammation in a Mouse Model of Asthma","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/imcb.12375","article-title":"CC Chemokine Receptor 6 (CCR6) in the Pathogenesis of Systemic Lupus Erythematosus","volume":"98","author":"Lee","year":"2020","journal-title":"Immunol. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.smim.2003.08.006","article-title":"Chemokines on the Move: Control by the Chemokine \u201cInterceptors\u201d Duffy Blood Group Antigen and D6","volume":"15","author":"Nibbs","year":"2003","journal-title":"Semin. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nri1964","article-title":"Tuning Inflammation and Immunity by Chemokine Sequestration: Decoys and More","volume":"6","author":"Mantovani","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nri3544","article-title":"Immune Regulation by Atypical Chemokine Receptors","volume":"13","author":"Nibbs","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Colin, P., Zhou, Z., Staropoli, I., Garcia-Perez, J., Gasser, R., Armani-Tourret, M., Benureau, Y., Gonzalez, N., Jin, J., and Connell, B.J. (2018). CCR5 Structural Plasticity Shapes HIV-1 Phenotypic Properties. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007432"},{"key":"ref_19","unstructured":"Surbhi, S. (2023, January 03). Phase II Study of MGTA-145 in Combination with Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Patients With Multiple Myeloma, Available online: Clinicaltrials.gov."},{"key":"ref_20","unstructured":"(2023, January 03). MAVORIXAFOR\u2014Compound Report Card. Available online: https:\/\/www.ebi.ac.uk\/chembl\/compound_report_card\/CHEMBL518924\/."},{"key":"ref_21","unstructured":"(2023, January 03). VERCIRNON\u2014Compound Report Card. Available online: https:\/\/www.ebi.ac.uk\/chembl\/compound_report_card\/CHEMBL2178578\/."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nri2972","article-title":"Overcoming Hurdles in Developing Successful Drugs Targeting Chemokine Receptors","volume":"11","author":"Schall","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1\u03b1, and MIP-1\u03b2 as the Major HIV-Suppressive Factors Produced by CD8+ T Cells","volume":"270","author":"Cocchi","year":"1995","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1074\/jbc.273.8.4289","article-title":"Monocyte Chemotactic Protein-2 Activates CCR5 and Blocks CD4\/CCR5-Mediated HIV-1 Entry\/Replication*","volume":"273","author":"Gong","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1182\/blood.V95.10.3032","article-title":"Chemokine Receptors and Their Role in Inflammation and Infectious Diseases","volume":"95","author":"Murdoch","year":"2000","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1084\/jem.186.1.165","article-title":"Identification of CCR8: A Human Monocyte and Thymus Receptor for the CC Chemokine I-309","volume":"186","author":"Tiffany","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1189\/jlb.1102577","article-title":"Expression and Function of Chemokines during Viral Infections: From Molecular Mechanisms to in Vivo Function","volume":"74","author":"Melchjorsen","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10555-006-9027-x","article-title":"CCL2 (Monocyte Chemoattractant Protein-1) in Cancer Bone Metastases","volume":"25","author":"Craig","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8403937","DOI":"10.1155\/2018\/8403937","article-title":"Serum Cytokine Profiles in Patients with Dengue Fever at the Acute Infection Phase","volume":"2018","author":"Huang","year":"2018","journal-title":"Dis. Markers"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12404","DOI":"10.1074\/jbc.M006327200","article-title":"Identification of Human Macrophage Inflammatory Proteins 1\u03b1 and 1\u03b2 as a Native Secreted Heterodimer*","volume":"276","author":"Guan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_31","unstructured":"(2022, November 09). CCL3 C-C Motif Chemokine Ligand 3 [Homo Sapiens (Human)]\u2014Gene\u2014NCBI, Available online: https:\/\/www.ncbi.nlm.nih.gov\/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=6348."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.emboj.7600947","article-title":"HIV and the Chemokine System: 10 Years Later","volume":"25","author":"Lusso","year":"2006","journal-title":"EMBO J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"826621","DOI":"10.3389\/fimmu.2021.826621","article-title":"The Dual Role of CCR5 in the Course of Influenza Infection: Exploring Treatment Opportunities","volume":"12","author":"Ferrero","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/acel.12294","article-title":"MicroRNA-125b Modulates Inflammatory Chemokine CCL4 Expression in Immune Cells and Its Reduction Causes CCL4 Increase with Age","volume":"14","author":"Cheng","year":"2015","journal-title":"Aging Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.4049\/jimmunol.1602121","article-title":"RIG-I\u2013like Receptor Triggering by Dengue Virus Drives Dendritic Cell Immune Activation and TH1 Differentiation","volume":"198","author":"Sprokholt","year":"2017","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1471-4906(00)01812-3","article-title":"RANTES: A Versatile and Controversial Chemokine","volume":"22","author":"Appay","year":"2001","journal-title":"Trends Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.4049\/jimmunol.172.3.1872","article-title":"The C10\/CCL6 Chemokine and CCR1 Play Critical Roles in the Pathogenesis of IL-13-Induced Inflammation and Remodeling","volume":"172","author":"Ma","year":"2004","journal-title":"J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S1679-45082015RB3438","article-title":"Chemokines and Immunity","volume":"13","author":"Palomino","year":"2015","journal-title":"Einstein (S\u00e3o Paulo)"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e4928","DOI":"10.7717\/peerj.4928","article-title":"Crucial Biological Functions of CCL7 in Cancer","volume":"6","author":"Liu","year":"2018","journal-title":"PeerJ"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ge, B., Li, J., Wei, Z., Sun, T., Song, Y., and Khan, N.U. (2017). Functional Expression of CCL8 and Its Interaction with Chemokine Receptor CCR3. BMC Immunol., 18.","DOI":"10.1186\/s12865-017-0237-5"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.1005201108","article-title":"Recruited Inflammatory Monocytes Stimulate Antiviral Th1 Immunity in Infected Tissue","volume":"108","author":"Iijima","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.1074\/jbc.271.13.7725","article-title":"Molecular Cloning of Human Eotaxin, an Eosinophil-Selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3 (*)","volume":"271","author":"Kitaura","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1182\/blood.V97.7.1920","article-title":"Eotaxin Is a Natural Antagonist for CCR2 and an Agonist for CCR5","volume":"97","author":"Ogilvie","year":"2001","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.2147\/JIR.S329697","article-title":"Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections","volume":"14","author":"Liu","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40139-021-00226-0","article-title":"Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19","volume":"9","author":"Julian","year":"2021","journal-title":"Curr. Pathobiol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41591-021-01643-9","article-title":"A Guide to Immunotherapy for COVID-19","volume":"28","author":"Pickkers","year":"2022","journal-title":"Nat. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.str.2019.02.004","article-title":"Advancing Chemokine GPCR Structure Based Drug Discovery","volume":"27","author":"Zhao","year":"2019","journal-title":"Structure"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.tips.2022.09.009","article-title":"Atypical Chemokine Receptors: Emerging Therapeutic Targets in Cancer","volume":"43","author":"Torphy","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3389\/fendo.2021.711906","article-title":"Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors","volume":"12","author":"Langer","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"9510","DOI":"10.1038\/s41598-021-88939-5","article-title":"GPCR_LigandClassify.Py; a Rigorous Machine Learning Classifier for GPCR Targeting Compounds","volume":"11","author":"Ahmed","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep Learning","volume":"521","author":"LeCun","year":"2015","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"11981","DOI":"10.1038\/s41598-020-68771-z","article-title":"Early Detection of Type 2 Diabetes Mellitus Using Machine Learning-Based Prediction Models","volume":"10","author":"Kopitar","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_54","unstructured":"Ke, G., Meng, Q., Finley, T., Wang, T., Chen, W., Ma, W., Ye, Q., and Liu, T.-Y. (2017, January 4\u20139). LightGBM: A Highly Efficient Gradient Boosting Decision Tree. Proceedings of the Advances in Neural Information Processing Systems, Long Beach, CA, USA."},{"key":"ref_55","unstructured":"Gull\u00ec, A., and Pal, S. (2017). Deep Learning with Keras: Implement Neural Networks with Keras on Theano and TensorFlow, Packt Publishing."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Mizera, M., and Latek, D. (2021). Ligand-Receptor Interactions and Machine Learning in GCGR and GLP-1R Drug Discovery. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084060"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Mizera, M., Latek, D., and Cielecka-Piontek, J. (2020). Virtual Screening of C. Sativa Constituents for the Identification of Selective Ligands for Cannabinoid Receptor 2. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155308"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Latek, D., Rutkowska, E., Niewieczerzal, S., and Cielecka-Piontek, J. (2019). Drug-Induced Diabetes Type 2: In Silico Study Involving Class B GPCRs. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0208892"},{"key":"ref_59","unstructured":"(2022, November 21). Enamine. Available online: https:\/\/enamine.net\/."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"D440","DOI":"10.1093\/nar\/gkx1109","article-title":"GPCRdb in 2018: Adding GPCR Structure Models and Ligands","volume":"46","author":"Munk","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER Suite: Protein Structure and Function Prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I-TASSER: A Unified Platform for Automated Protein Structure and Function Prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat. Protoc."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Zhang, Y. (2008). I-TASSER Server for Protein 3D Structure Prediction. BMC Bioinform., 9.","DOI":"10.1186\/1471-2105-9-40"},{"key":"ref_64","unstructured":"(2022, February 08). Robetta. Available online: https:\/\/robetta.bakerlab.org\/."},{"key":"ref_65","unstructured":"(2022, February 08). The PyMOL Molecular Graphics System, Schr\u00f6dinger. Available online: https:\/\/pymol.org\/2\/."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nature20605","article-title":"Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists","volume":"540","author":"Zheng","year":"2016","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.str.2018.10.027","article-title":"Crystal Structure of CC Chemokine Receptor 2A in Complex with an Orthosteric Antagonist Provides Insights for the Design of Selective Antagonists","volume":"27","author":"Apel","year":"2019","journal-title":"Structure"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1038\/s41467-021-24438-5","article-title":"Structural Basis for Chemokine Recognition and Receptor Activation of Chemokine Receptor CCR5","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"eabg8685","DOI":"10.1126\/sciadv.abg8685","article-title":"Structural Basis of the Activation of the CC Chemokine Receptor 5 by a Chemokine Agonist","volume":"7","author":"Isaikina","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.1241475","article-title":"Structure of the CCR5 Chemokine Receptor\u2013HIV Entry Inhibitor Maraviroc Complex","volume":"341","author":"Tan","year":"2013","journal-title":"Science"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2017.05.002","article-title":"Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV","volume":"46","author":"Zheng","year":"2017","journal-title":"Immunity"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9621","DOI":"10.1021\/acs.jmedchem.8b01077","article-title":"Structure-Based Design of 1-Heteroaryl-1,3-Propanediamine Derivatives as a Novel Series of CC-Chemokine Receptor 5 Antagonists","volume":"61","author":"Peng","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41586-018-0804-9","article-title":"Structural Basis of Coreceptor Recognition by HIV-1 Envelope Spike","volume":"565","author":"Shaik","year":"2019","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1038\/s41467-020-16820-6","article-title":"Structural Basis for Chemokine Receptor CCR6 Activation by the Endogenous Protein Ligand CCL20","volume":"11","author":"Wasilko","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_75","unstructured":"(2021). Schr\u00f6dinger Release 2021-4: Maestro, Schr\u00f6dinger, LLC. Available online: https:\/\/www.schrodinger.com\/products\/maestro."},{"key":"ref_76","unstructured":"(2021). Schr\u00f6dinger Release 2021-4: Ligprep, Schr\u00f6dinger, LLC. Available online: https:\/\/www.schrodinger.com\/products\/ligprep."},{"key":"ref_77","unstructured":"(2021). Schr\u00f6dinger Release 2021-4: Glide, Schr\u00f6dinger, LLC. Available online: https:\/\/www.schrodinger.com\/products\/glide."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL Database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: A Large-Scale Bioactivity Database for Drug Discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","article-title":"Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking","volume":"55","author":"Mysinger","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1039\/b409813g","article-title":"Molecular Similarity: A Key Technique in Molecular Informatics","volume":"2","author":"Bender","year":"2004","journal-title":"Org. Biomol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1021\/c160017a018","article-title":"The Generation of a Unique Machine Description for Chemical Structures-A Technique Developed at Chemical Abstracts Service","volume":"5","author":"Morgan","year":"1965","journal-title":"J. Chem. Doc."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1021\/jm301916b","article-title":"Hit Identification and Optimization in Virtual Screening: Practical Recommendations Based on a Critical Literature Analysis: Miniperspective","volume":"56","author":"Zhu","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1021\/jm010548w","article-title":"Molecular Docking and High-Throughput Screening for Novel Inhibitors of Protein Tyrosine Phosphatase-1B","volume":"45","author":"Doman","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1517\/14656561003801081","article-title":"Treatment of HIV Infection with the CCR5 Antagonist Maraviroc","volume":"11","author":"Kromdijk","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Pasznik, P., Rutkowska, E., Niewieczerzal, S., Cielecka-Piontek, J., and Latek, D. (2019). Potential Off-Target Effects of Beta-Blockers on Gut Hormone Receptors: In Silico Study Including GUT-DOCK\u2014A Web Service for Small-Molecule Docking. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210705"},{"key":"ref_87","unstructured":"Schr\u00f6dinger Release 2022-3: SiteMap, Schr\u00f6dinger, LLC. Available online: https:\/\/www.schrodinger.com\/products\/sitemap."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/2\/516\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:23:38Z","timestamp":1760120618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/2\/516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":87,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["pharmaceutics15020516"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics15020516","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}